Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EG.2.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EG.2.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FK.1.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FK.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FK.1.1.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FK.1.1.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FK.1.1.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FK.1.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FK.1.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FK.1.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FT.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FT.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FT.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FT.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FT.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FT.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FT.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FT.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XBF.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FY.1.2.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FY.1.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.1.2.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FY.1.2.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FY.1.2.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FY.1.2.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FY.1.2.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.1.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.11.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GK.1.11.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.11.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GK.1.11.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GK.1.11.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GK.1.11.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GK.1.11.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.1.11.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.32.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-1649.2South Korea
FL.32.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-1935.15South Korea
FL.32.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-2824.15Germany
FL.32.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-3196.01Germany
FL.32.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-3064.43China
FL.32.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-3384China
FL.32.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-2013.34China
FL.32.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.8.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GA.8.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.8.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GA.8.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GA.8.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GA.8.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used